Latest / PETRI DISH PERSPECTIVES
Episode 43: ARCH Venture Partners
Send us Fan Mail
In this episode of Petri Dish Perspectives, we unpack the strategy and scientific conviction behind ARCH Venture Partners, the venture firm that has quietly helped build some of the most transformative companies in modern biotechnology. From early bets on platform technologies like gene editing and mRNA to backing next-generation leaders such as Juno, Editas Medicine, Beam Therapeutics, and rising metabolic players like Metsera, ARCH has consistently invested at the frontier, long before the science was commercially proven.
We explore how ARCH’s concentrated, high-conviction…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.